Dozens of commonly prescribed medications can cause breast tissue growth in men, a condition called gynecomastia. The underlying cause is always the same: the medication shifts the balance between estrogen and testosterone in a way that lets estrogen stimulate breast tissue. How that shift happens varies by drug class, and some medications carry far higher risk than others.
How Medications Trigger Breast Growth
Male breast tissue contains receptors for both estrogen and testosterone. Normally, testosterone keeps estrogen’s growth-promoting effects in check. When a drug tips the ratio in estrogen’s favor, breast tissue can enlarge. This can happen through several routes: a medication may block testosterone from doing its job, raise estrogen levels directly, interfere with how the body breaks down estrogen, or increase a hormone called prolactin that stimulates breast tissue on its own.
The result is the same regardless of the pathway. Breast tissue grows, sometimes on one side, sometimes both. It can be painless or tender. Understanding which mechanism your medication uses helps explain why it happened and what to expect if you stop taking it.
Spironolactone and Heart Medications
Spironolactone is one of the most well-documented causes of drug-induced gynecomastia. It’s prescribed for heart failure, high blood pressure, and fluid retention. About 10% of men taking it develop breast enlargement or breast discomfort, and the risk climbs steeply with dose. At doses above 150 mg per day, up to 52% of men experience this side effect.
Spironolactone works through multiple mechanisms at once. It competes with testosterone for binding sites on cells, effectively blocking testosterone’s action. It can also lower testosterone levels in the blood while raising estrogen levels, particularly with long-term or high-dose use. Unlike some other drug-induced breast changes, spironolactone-related enlargement tends to be bilateral, painless, and clearly tied to how much you’re taking.
Other heart medications, including certain calcium channel blockers and digoxin, have also been linked to gynecomastia, though less frequently than spironolactone.
Hair Loss and Prostate Drugs
Finasteride and dutasteride, known as 5-alpha reductase inhibitors, are prescribed for male pattern baldness and enlarged prostate. They work by blocking the enzyme that converts testosterone into its more potent form. The unintended consequence: testosterone levels rise, and excess testosterone gets converted into estrogen by a different enzyme in the liver. That shift in the estrogen-to-testosterone ratio can trigger breast growth.
The risk depends on dose. At the 5 mg daily dose used for prostate conditions, clinical trials have reported gynecomastia rates ranging from 0.3% to 4.5%. Dutasteride at 0.5 mg daily shows rates between 1% and 2.3%. At the lower 1 mg dose of finasteride used for hair loss, breast enlargement wasn’t flagged as a side effect in the original large trial, though individual cases have been reported since. Among the 214 cases reported to the FDA’s adverse event system, about 30% were one-sided, 25% were bilateral, and the rest weren’t specified. Roughly 80% saw partial or complete improvement, while 20% had no change.
Antipsychotic Medications
Antipsychotics cause breast growth through a different mechanism than most other drugs on this list. They block dopamine receptors in the pituitary gland, which removes the brain’s normal brake on prolactin production. Prolactin levels surge, and because male breast tissue has prolactin receptors, the hormone can directly stimulate growth.
Not all antipsychotics carry equal risk. Risperidone is the most commonly implicated, with documented cases of both one-sided and bilateral breast enlargement. Older, first-generation antipsychotics also tend to raise prolactin significantly. By contrast, several newer antipsychotics, including clozapine, olanzapine, aripiprazole, ziprasidone, and quetiapine, are considered “prolactin-sparing” and carry a lower risk. That said, individual cases have been reported even with these medications, so the risk isn’t zero.
Stomach Acid Medications
Cimetidine, an older heartburn and ulcer drug sold as Tagamet, is a well-known cause of gynecomastia. A study published in the New England Journal of Medicine pinpointed why: cimetidine interferes with the liver enzyme responsible for breaking down estrogen. In nine healthy men, two weeks of cimetidine reduced the body’s ability to metabolize estrogen by about 38%, and blood estrogen levels rose by approximately 20%. Even at a lower dose taken for just one week, estrogen metabolism dropped significantly.
This effect is specific to cimetidine. Ranitidine, a newer drug in the same class, was tested in the same study and had no effect on estrogen metabolism. If you’re taking an H2 blocker and concerned about this side effect, the newer options in this drug class don’t appear to carry the same risk.
Testosterone Replacement Therapy
It sounds counterintuitive, but taking testosterone can cause breast growth. When you introduce extra testosterone from outside the body, some of it gets converted into estrogen through a process called aromatization. If estrogen levels climb faster than testosterone’s effects can counterbalance them, the ratio tips and breast tissue responds. Between 10% and 25% of men on testosterone replacement therapy experience gynecomastia or breast pain.
The key factor is the ratio of estrogen to testosterone, not the absolute level of either hormone. This is why gynecomastia can develop even when testosterone levels look normal or high on a blood test. Monitoring typically involves checking both testosterone and estrogen levels to catch an imbalance before symptoms progress.
Other Medications Linked to Breast Growth
Several other drug categories have been associated with gynecomastia, though sometimes through mechanisms that aren’t fully understood:
- Anti-androgens used in prostate cancer treatment directly block testosterone’s effects on tissue, creating a strong estrogen-dominant environment.
- Certain antidepressants and anti-anxiety medications have been linked to breast changes in isolated reports, though the connection is less consistent than with the drugs listed above.
- Anabolic steroids work similarly to testosterone therapy. Excess steroids get converted to estrogen, and because they also suppress the body’s natural testosterone production, the hormonal imbalance can be severe.
- Some HIV medications, particularly efavirenz, have been associated with gynecomastia in case reports.
For many of these, breast enlargement appears to be an uncommon, individual reaction rather than a predictable dose-dependent effect. The fact that millions of people take these drugs without issue suggests some men are simply more susceptible, possibly due to genetic differences in how they metabolize hormones.
Does It Go Away After Stopping the Drug?
In many cases, yes. Gynecomastia often resolves on its own once the medication causing it is discontinued. But timing matters enormously. Breast tissue that has been present for more than about a year tends to develop fibrosis, a scarring process that makes the tissue permanent. Once fibrosis sets in, the enlargement won’t reverse on its own, and surgery becomes the only effective option.
This is why early recognition is important. If you notice breast tenderness, swelling, or a firm lump behind the nipple while taking any of the medications described above, raising the issue with your prescriber sooner rather than later gives you the best chance of reversal. In some cases, switching to an alternative medication or adjusting the dose is enough to resolve the problem. Waiting months to see if it goes away on its own can narrow your options.
How Severity Is Assessed
Clinicians use a grading system to describe the extent of gynecomastia. Grade I is small enlargement with no excess skin. Grade IIa is moderate enlargement, still without loose skin. Grade IIb adds minor skin excess. Grade III is marked enlargement with significant extra skin resembling female breast development. Lower grades are more likely to resolve with medication changes alone, while higher grades, especially with skin excess, are more likely to require surgical correction if they’ve been present long enough to develop permanent tissue changes.
The evaluation typically includes a physical exam, a review of all current medications and supplements, and blood tests checking hormone levels, thyroid function, and liver and kidney health. Breast imaging may be used when the physical exam is unclear, partly to rule out the rare possibility of male breast cancer, which can present with similar symptoms but tends to be one-sided, painless, and firm.